iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
- 15 April 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (8), 1681-1692
- https://doi.org/10.1158/0008-5472.CAN-19-2991
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to radiotherapy, chemotherapy, or a combination of these modalities, and surgery remains the only curative intervention for localized disease. Although cancer-associated fibroblasts (CAF) are abundant in PDAC tumors, the effects of radiotherapy on CAFs and the response of PDAC cells to radiotherapy are unknown. Using patient samples and orthotopic PDAC biological models, we showed that radiotherapy increased inducible nitric oxide synthase (iNOS) in the tumor tissues. Mechanistic in vitro studies showed that, although undetectable in radiotherapy-activated tumor cells, iNOS expression and nitric oxide (NO) secretion were significantly increased in CAFs secretome following radiotherapy. Culture of PDAC cells with conditioned media from radiotherapy-activated CAFs increased iNOS/NO signaling in tumor cells through NF-kappa B, which, in turn, elevated the release of inflammatory cytokines by the tumor cells. Increased NO after radiotherapy in PDAC contributed to an acidic microenvironment that was detectable using the radiolabeled pH (low) insertion peptide (pHLIP). In murine orthotopic PDAC models, pancreatic tumor growth was delayed when iNOS inhibition was combined with radiotherapy. These data show the important role that iNOS/NO signaling plays in the effectiveness of radiotherapy to treat PDAC tumors. Significance: Aradiolabeled pH-targeted peptide can be used as a PET imaging tool to assess therapy response within PDAC and blocking iNOS/NO signaling may improve radiotherapy outcomes.Other Versions
Funding Information
- NIH (P30 CA08748)
- Geoffrey Beene Cancer Research Center of MSKCC (NIH NCI R35 CA232130)
This publication has 65 references indexed in Scilit:
- Family of pH (low) insertion peptides for tumor targetingProceedings of the National Academy of Sciences of the United States of America, 2013
- Long-Term Nitric Oxide Exposure Enhances Lung Cancer Cell MigrationBioMed Research International, 2013
- Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2Cell, 2011
- Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin SignalingCancer Research, 2011
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive ImmunityCancer Research, 2011
- Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patientsJCI Insight, 2010
- Recent advances in radiotherapyBMC Medicine, 2010
- Nitric Oxide in Physiologic Concentrations Targets the Translational Machinery to Increase the Proliferation of Human Breast Cancer Cells: Involvement of Mammalian Target of Rapamycin/eIF4E PathwayCancer Research, 2007
- A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasisOncogene, 2003
- Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generationBiochemical and Biophysical Research Communications, 1992